Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: BIRR 4; sICAM; sICAM-rhinovirus; soluble ICAM-1; tremacamra

Latest Information Update: 08 May 2003

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Boehringer Ingelheim
  • Developer Boehringer Ingelheim; Isis Pharmaceuticals
  • Class Antivirals; Glycoproteins
  • Mechanism of Action Immunomodulators; Virus attachment inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported HIV-1 infections
  • Discontinued Diabetes mellitus; Rhinovirus infections

Most Recent Events

  • 08 May 2003 Discontinued - Preclinical for Diabetes mellitus in Germany (unspecified route)
  • 29 Sep 2000 Discontinued-II for Rhinovirus infections in USA (Intranasal)
  • 29 Sep 2000 Discontinued-Preclinical for Rhinovirus infections in Germany (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top